Table 4.
MSE performance measures according to route of exploration
| Anterograde | Retrograde | |
|---|---|---|
| n = 74 | n = 62 | |
| Technical success | 68 (91.9%) | 56 (90.3%) |
| Oesophageal dilation | 13 (17.6%) | – |
| Diagnostic yield | 53 (71.6%) | 38 (61.3%) |
| Time to SB | 4 (3–6) | 10 (7–15) |
| SBIT | 32 (25–50) | 31 (21–48) |
| DMI | 415 (264–585) | 120 (37–225) |
| TPT | 60 (51–89) | 56 (45–71) |
| Abdominal surgery | 33 (44.6%) | 26 (41.9%) |
| Total AEs | 8 (10.8%) | 6 (9.7%) |
| SAE | 2 (2.7%) | – |
| Therapeutic yield | 41 (55.4%) | 15 (24.2%) |
| Biopsies | 18 (24.3%) | 23 (37.1%) |
| Interventional Yield | 56 (75.7%) | 36 (58.1%) |
| Tattoos | 50 (67.6%) | 36 (58.1%) |
Values are expressed as number (percentage) or median (interquartile range)
AE adverse event, DMI depth of maximum insertion, SAE serious adverse event, SBIT small bowel insertion time, TPT total procedure time